Dr. Alvanus Hartley, MD
995 Prince Frederick Blvd, Suite 204, Prince Frederick, MD 20678 • +1-307-555-8128
Medical Education: Accredited U.S. Medical School (Class of 2016)
What This Doctor Actually Performs: CMS Medicare Utilization & Prince Frederick Percentiles
NPI #1336213503 • CBSA Regional • Dermatology
CMS Medicare Part B utilization records credit Dr. Alvanus Hartley (MD, NPI 1336213503) at 995 Prince Frederick Blvd, Suite 204 in Prince Frederick with 2,025 annual clinical services (499 beneficiaries), corresponding to a -0.69σ regional deviation and focused low-volume boutique caseload (0th Prince Frederick percentile) with sub-specialty concentration in 52 Active CMS HCPCS Codes.
Procedural volume for Dr. Hartley is led by HCPCS 17000 (Cryotherapy Destruction of Premalignant Actinic Lesion — 671 annual services, $87–$119 GPCI cash estimate), followed by CPT 99213 (Focused Cutaneous & Dermoscopic Examination, 612/yr) and CPT 11102 (Tangential Diagnostic Skin Biopsy of Single Lesion, 375/yr).
Cash-pay intake data for NPI 1336213503 (995 Prince Frederick Blvd, Suite 204, Prince Frederick) indicates $209.00 typical out-of-pocket visit spend against a $209.00 locality benchmark, paired with 21-minute average reception wait and 4.82/5 biomarker openness.
Clinical background for Dr. Hartley (MD, NPI #1336213503) includes accredited doctoral training (2016, 10 yrs in practice) and dedicated on-site consultations at 995 Prince Frederick Blvd, Suite 204.
Compared against Prince Frederick, MD Dermatology peers
2,025 annual services across 499 beneficiaries
Standard deviations from MD Dermatology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 17000 | Cryotherapy Destruction of Premalignant Actinic Lesion | 671 | 12th | $87 – $119 |
| 99213 | Focused Cutaneous & Dermoscopic Examination | 612 | 12th | $97 – $133 |
| 11102 | Tangential Diagnostic Skin Biopsy of Single Lesion | 375 | 12th | $128 – $175 |
| 11401 | Excision of Benign Cutaneous Lesion (0.6 to 1.0 cm) | 197 | 12th | $179 – $246 |
| 99203 | New Patient Full-Body Skin Cancer & Dermatology Evaluation | 118 | 12th | $138 – $189 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (52 HCPCS billing breadth) | 52 | 0th | $106 – $154 |
Are you Dr. Alvanus Hartley? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Prince Frederick, MD:
<a href="https://dotmd.com/doctors/alvanus-hartley-md-prince-frederick-md-1336213503" title="Dr. Alvanus Hartley, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1336213503.svg" alt="Dr. Alvanus Hartley Dermatology Badge" width="280" height="72" /></a>
Dr. Alvanus Hartley, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Hartley National Provider Identifier | NPI #1336213503 (MD) | CMS NPPES Registry (20678) |
| Dr. Hartley Prince Frederick CMS Volume Rank | 0.00th Pct (2,025 CMS svcs; Z -0.694σ) | CMS Medicare Part B (MD Dermatology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Prince Frederick, MD) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 21 min lobby wait | 15 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.56/5 Listening • 4.82/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Alvanus Hartley
Other High-Volume Dermatology Specialists in Prince Frederick, MD
Ranked strictly by CMS Medicare volumeDr. Hartley Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Prince Frederick, MD.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Alvanus Hartley community threads and patient logs by age, biological sex, dosage, and treatment duration.